StonvexLoading…
StonvexStonvexStonvexCore line items from VRSK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.07B | $2.88B | $2.68B | $2.50B |
Operating Income | $1.34B | $1.25B | $1.13B | $1.41B |
Net Income | $908.30M | $958.20M | $614.60M | $953.90M |
EPS (Diluted) | $6.48 | $6.71 | $4.17 | $6.00 |
Total Assets | $6.20B | $4.26B | $4.37B | $6.96B |
Total Liabilities | $5.89B | $4.16B | $4.04B | $5.19B |
Cash & Equivalents | $2.18B | $291.20M | $302.70M | $112.50M |
Free Cash Flow OCF − CapEx | $1.19B | $920.10M | $830.70M | $784.30M |
Shares Outstanding | 138.40M | 140.41M | 143.31M | 154.70M |